Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nantong Jinghai Amino Acid is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale production of high-quality amino acids. Established in 1995, the company has become a leading supplier of pharmaceutical-grade amino acids used in parenteral and enteral nutrition, as well as raw materials for peptide synthesis and specialized medical foods. Their product portfolio includes a wide range of essential and non-essential amino acids such as L-Isoleucine, L-Valine, and L-Leucine, produced via fermentation and extraction processes. The company operates under strict GMP standards and serves both domestic and international markets, providing critical components for the pharmaceutical, healthcare, and food industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinghai Amino Acid.